We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
PIM
901
Penobscot Investment Management
Massachusetts
$3.69M
TF
902
Tompkins Financial
New York
$3.65M +$245K +7,800 +7%
FHA
903
First Horizon Advisors
Tennessee
$3.65M -$87.2K -2,773 -2%
CT
904
Coastline Trust
Rhode Island
$3.65M +$39.5K +1,254 +1%
AT
905
AMF Tjänstepension
Sweden
$3.64M -$17.3M -550,926 -82%
GI
906
Gradient Investments
Minnesota
$3.64M +$144K +4,584 +4%
SSB
907
Sandy Spring Bank
Maryland
$3.63M -$153K -4,870 -4%
MRCM
908
M&R Capital Management
New Jersey
$3.63M +$266K +8,459 +8%
FAM
909
Fred Alger Management
New York
$3.62M -$1.91M -60,686 -34%
PTC
910
Private Trust Company
Ohio
$3.62M -$47.6K -1,513 -1%
IAA
911
Ironsides Asset Advisors
North Carolina
$3.6M +$880K +27,984 +31%
ICAS
912
Investors Capital Advisory Services
Massachusetts
$3.6M -$370K -11,767 -9%
RFS
913
Rockefeller Financial Services
New York
$3.58M +$167K +5,296 +5%
RT
914
Rockland Trust
Massachusetts
$3.57M +$193K +6,120 +6%
KS
915
Karpas Strategies
Connecticut
$3.56M -$82.9K -2,635 -2%
DJSG
916
D.J. St. Germain
Massachusetts
$3.56M +$522K +16,603 +17%
BAMS
917
Bellevue Asset Management (Switzerland)
Switzerland
$3.55M +$829K +26,350 +29%
BAAM
918
Baker Avenue Asset Management
California
$3.53M -$747K -23,758 -17%
Edgewood Management
919
Edgewood Management
Connecticut
$3.5M
BMO
920
Beck Mack & Oliver
New York
$3.49M -$496K -15,764 -12%
M
921
MOTCO
Texas
$3.47M -$209K -6,634 -6%
NAMA
922
Nikko Asset Management Americas
New York
$3.46M +$534K +16,969 +18%
RGI
923
River Global Investors
United Kingdom
$3.46M +$3.56M +113,101 New
OCM
924
Orleans Capital Management
Louisiana
$3.43M +$27.5K +873 +0.8%
PP
925
PDT Partners
New York
$3.43M +$1.41M +44,795 +67%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.